Efficacy of fulvestrant-based therapies in treating HR-positive, HER2-negative breast cancer with liver metastasis

被引：0
|
作者：
Chien, Christine
Madak-Erdogan, Zeynep
Goel, Mahima
Gangidi, Suma
Tripathy, Debu
Raghavendra, Akshara Singareeka
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P5-02-39
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-02-39
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Ribociclib in HR-positive, HER2-negative breast cancer
    Burki, Talha Khan
    LANCET ONCOLOGY, 2016, 17 (11): : E482 - E482
  • [2] Visceral metastases should distinguish between liver or lung when treating HR-positive/HER2-negative advanced breast cancer with fulvestrant
    He, M.
    Li, J. -J.
    Zuo, W. -J.
    Wang, Z. -H.
    Shao, Z. -M.
    BREAST, 2019, 44 : S59 - S59
  • [3] Updates to the Management of HR-Positive, HER2-Negative Breast Cancer
    Gradishar, William J.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2024, 22
  • [4] Exemestane plus entinostat in HR-positive/HER2-negative breast cancer?
    Lichert, Frank
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (01) : 18 - 18
  • [5] Systemic Therapy of HR-positive, HER2-negative metastatic Breast Cancer
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (03) : 257 - 257
  • [6] Sacituzumab Govitecan in HR-positive HER2-negative metastatic breast cancer
    Nardin, Simone
    Del Mastro, Lucia
    ANNALS OF TRANSLATIONAL MEDICINE, 2023,
  • [7] How we treat HR-positive, HER2-negative early breast cancer
    Lopez-Tarruella, Sara
    Echavarria, Isabel
    Jerez, Yolanda
    Herrero, Blanca
    Gamez, Salvador
    Martin, Miguel
    FUTURE ONCOLOGY, 2022, 18 (08) : 1003 - 1022
  • [8] Palbociclib: A Review in HR-Positive, HER2-Negative, Advanced or Metastatic Breast Cancer
    Esther S. Kim
    Lesley J. Scott
    Targeted Oncology, 2017, 12 : 373 - 383
  • [9] Palbociclib: A Review in HR-Positive, HER2-Negative, Advanced or Metastatic Breast Cancer
    Kim, Esther S.
    Scott, Lesley J.
    TARGETED ONCOLOGY, 2017, 12 (03) : 373 - 383
  • [10] Role of everolimus in the treatment of metastatic HER2-negative/HR-positive breast cancer
    Pronzato, Paolo
    FUTURE ONCOLOGY, 2017, 13 (16) : 1371 - 1384
12345